NO177500C - Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant - Google Patents

Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant

Info

Publication number
NO177500C
NO177500C NO874905A NO874905A NO177500C NO 177500 C NO177500 C NO 177500C NO 874905 A NO874905 A NO 874905A NO 874905 A NO874905 A NO 874905A NO 177500 C NO177500 C NO 177500C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
hirudin variant
active hirudin
variant
Prior art date
Application number
NO874905A
Other languages
English (en)
Other versions
NO874905D0 (no
NO874905L (no
NO177500B (no
Inventor
Michael Courtney
Eric Degryse
Gerard Loison
Yves Lemoine
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of NO874905D0 publication Critical patent/NO874905D0/no
Publication of NO874905L publication Critical patent/NO874905L/no
Publication of NO177500B publication Critical patent/NO177500B/no
Publication of NO177500C publication Critical patent/NO177500C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
NO874905A 1986-12-01 1987-11-25 Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant NO177500C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR868616723A FR2607517B2 (fr) 1986-12-01 1986-12-01 Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Publications (4)

Publication Number Publication Date
NO874905D0 NO874905D0 (no) 1987-11-25
NO874905L NO874905L (no) 1988-06-02
NO177500B NO177500B (no) 1995-06-19
NO177500C true NO177500C (no) 1995-09-27

Family

ID=9341393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874905A NO177500C (no) 1986-12-01 1987-11-25 Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant

Country Status (24)

Country Link
US (1) US5650301A (no)
EP (1) EP0273800B1 (no)
JP (1) JP2567263B2 (no)
KR (1) KR960011918B1 (no)
AT (1) ATE73462T1 (no)
AU (1) AU617989B2 (no)
BG (1) BG49719A3 (no)
CA (1) CA1341416C (no)
CS (1) CS276245B6 (no)
DE (1) DE3777367D1 (no)
DK (1) DK173247B1 (no)
ES (1) ES2032465T3 (no)
FI (1) FI99211C (no)
FR (1) FR2607517B2 (no)
GR (1) GR3004556T3 (no)
HU (1) HU213871B (no)
IE (1) IE60544B1 (no)
MC (1) MC1884A1 (no)
NO (1) NO177500C (no)
PL (1) PL157254B1 (no)
PT (1) PT86233B (no)
RO (1) RO106890B1 (no)
SU (1) SU1687032A3 (no)
ZA (1) ZA879011B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2628429B1 (fr) * 1988-03-08 1990-12-28 Transgene Sa Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir
GB8817161D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Modified proteins
GB8817160D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Novel proteins
US5284768A (en) * 1988-08-24 1994-02-08 Sanofi Signal peptide, DNA sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide
US5879926A (en) * 1989-03-31 1999-03-09 Transgene S.A. Yeast strains for the production of mature heterologous proteins, especially hirudin
FR2645174B1 (fr) * 1989-03-31 1994-01-07 Transgene Sa Souches de levure ameliorees pour la production de proteines heterologues matures en particulier d'hirudine et procede de preparation d'hirudine correspondant
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
FR2656531B1 (fr) * 1989-12-29 1992-04-24 Sanofi Sa Promoteur artificiel pour l'expression de proteines dans le levure.
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
ATE140929T1 (de) * 1990-11-08 1996-08-15 Japan Energy Corp Hirudinmutante, deren herstellung, antikoagulans, sekretorischer vektor, durch besagten vektor transformierter mikroorganismus und herstellung eines produkts durch besagten mikroorganismus
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
US5407822A (en) * 1991-10-02 1995-04-18 Sanofi Artificial promoter for the expression of proteins in yeast
JP7375012B2 (ja) * 2019-04-16 2023-11-07 サンゲン バイオサイエンス カンパニー,リミテッド ヒルジン突然変異体の抽出・精製方法およびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.

Also Published As

Publication number Publication date
AU617989B2 (en) 1991-12-12
FI99211C (fi) 1997-10-27
NO874905D0 (no) 1987-11-25
CS276245B6 (en) 1992-05-13
BG49719A3 (en) 1992-01-15
DK173247B1 (da) 2000-05-22
EP0273800A2 (fr) 1988-07-06
KR880007729A (ko) 1988-08-29
PT86233B (pt) 1990-11-07
PT86233A (fr) 1987-12-01
ATE73462T1 (de) 1992-03-15
DE3777367D1 (de) 1992-04-16
HUT45564A (en) 1988-07-28
FR2607517B2 (fr) 1989-12-22
GR3004556T3 (no) 1993-04-28
JPS63152987A (ja) 1988-06-25
IE60544B1 (en) 1994-07-27
ZA879011B (en) 1988-05-27
CA1341416C (fr) 2003-01-21
EP0273800B1 (fr) 1992-03-11
CS8708732A2 (en) 1991-07-16
NO874905L (no) 1988-06-02
KR960011918B1 (ko) 1996-09-04
MC1884A1 (fr) 1989-01-24
DK627687D0 (da) 1987-11-30
FR2607517A2 (fr) 1988-06-03
FI875295A0 (fi) 1987-12-01
ES2032465T3 (es) 1993-02-16
PL269164A1 (en) 1988-08-18
HU213871B (en) 1997-11-28
FI99211B (fi) 1997-07-15
PL157254B1 (pl) 1992-05-29
DK627687A (da) 1988-06-02
JP2567263B2 (ja) 1996-12-25
US5650301A (en) 1997-07-22
SU1687032A3 (ru) 1991-10-23
EP0273800A3 (en) 1988-07-20
RO106890B1 (ro) 1993-07-30
IE873239L (en) 1988-06-01
FI875295A (fi) 1988-06-02
AU8188087A (en) 1988-06-02
NO177500B (no) 1995-06-19

Similar Documents

Publication Publication Date Title
NO177500C (no) Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant
FI892881A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi
DK340088D0 (da) Aminosyrederivater
DK631688A (da) 2',3'-dideoxy-2'-fluornucleosider, fremstillingen deraf samt praeparater indeholdende samme
NO177141C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyreantagonister
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
DK523288A (da) Aminosyrederivater
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
NO163692C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksazafosforin-4-tio-alkansulfonsyrer og salter derav.
GR3007995T3 (no)
NO178325C (no) Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat
NO178763C (no) Fremgangsmåte for fremstilling av racemisk og optisk aktiv 1,2,3,4-tetrahydroisochinolin-3-karboksylsyre samt mellomprodukter derav
DE2965364D1 (en) Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same
IT1188557B (it) Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
TR24462A (tr) Yuezeyi aktif doymus sulfofosforik asit(kismi) alkil esterleri
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
IL90333A0 (en) Process for the racemization of optically active d-2-n-phenacetyl-amino-4-methyl-phosphinobutyric acid
ATA259487A (de) Aminosaeure-oobt-ester
NO943458D0 (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin
IT1177962B (it) Composti 1,2,4-triazolici,procedimento per produrli e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
MK1K Patent expired